Palabras clave
Sistema cardiovascular
Enfermedad cardiovascular
Cómo citar
Copyright © | Todos los derechos reservados.
La revista posee los derechos de autor exclusivos para la publicación de este artículo en los términos de la ley brasileña 9610/98.
Reproducción parcial
El uso de partes de los textos, figuras y cuestionario del artículo es libre, siendo obligatoria la citación de los autores y revista.
Reproducción total
Está expresamente prohibido y debe ser autorizado por la revista.
Resumen
Objetivo: Analizar y correlacionar el impacto cardiovascular de la COVID-19 en pacientes con comorbilidades y los factores de riesgo asociados al daño causado por la infección, así como el pronóstico y su relación con la mortalidad. Métodos: Se trata de una revisión integradora de la literatura, con artículos publicados entre 2020 y 2023, incluyendo estudios observacionales y ensayos clínicos con texto completo disponible. La búsqueda se realizó en las siguientes bases de datos: National Libery of Medicine (Pubmed) y Portal Regional de la BVS. Como descriptores en la búsqueda de artículos se utilizaron: ´´Covid-19´´, impacto´´, ´´sistema cardiovascular´´, asociado al operador booleeriano ´´AND´´. Resultados: Se seleccionaron 11 artículos de la base de datos Pubmed y 8 artículos del portal regional de la BVS, siendo eliminados de este estudio 6 artículos por duplicación entre plataformas, resultando 19 artículos. Consideraciones finales: En conclusión es importante que los profesionales sanitarios sepan identificar y gestionar los cambios cardíacos durante el curso de la COVID-19, debido a su impacto en el sistema cardiovascular y la mortalidad.
Referencias
ÁGUILA-GORDO D. et al. Enfermedad cardiovascular tras infección por SARS-CoV-2 en pacientes ancianos. Resultados del seguimiento anual de una cohorte de supervivientes. Revista Española de Geriatría y Gerontología, 2021; 57(2): 100–104.
ALEKSOVA A, et al. Effects of SARS-CoV-2 on Cardiovascular System: The Dual Role of Angiotensin-Converting Enzyme 2 (ACE2) as the Virus Receptor and Homeostasis Regulator-Review. International Journal of Molecular Sciences, 2021; 22(9): 4526-4540.
ANALIS A, et al. COVID-19 infection and cardiac arrhythmias. Trends in Cardiovascular Medicine, 2020; 30(8): 451-460.
ARABADJIAN M, et al. COVID-19 in Adults With Hypertrophic Cardiomyopathy. Directory of Open Acces Journals, 2021; 8.
AZEVEDO R, et al. COVID-19 and the cardiovascular system: a comprehensive review. Journal of Huma Hypertension, 2020; 35(1): 4-11.
BOURGONJE AR, et al. Angiotensin‐converting enzyme 2 (ACE2), SARS‐CoV‐2 and the pathophysiology of coronavirus disease 2019 (COVID‐19). The Journal of Pathology, 2020; 251(3): 228-248.
CARO-CODÓN J, et al. Impact of the withdrawal of renin-angiotensin-aldosterone inhibitors on mortality in COVID-19 patients. Revista Portuguesa de Cardiologia. 2022; 41(10): 823-830.
CHEN Q, et l. Cardiovascular manifestations in severe and critical patients with COVID ‐19. Clinical Cardiology. 2020; 43(7): 796-802.
CONNORS JM e LEVY JH. COVID-19 and its implications for thrombosis and anticoagulation. Blood. 2020; 135(23): 2033-2040.
COSTA I, et al. Cardiovascular imaging and interventional procedures in patients with novel Coronavirus in infection. Arquivos brasileiros de cardiologia. 2020; 115(1): 111-116.
DA SILVA SJR. et al. Two Years into the COVID-19 Pandemic: Lessons Learned. ACS Infectious Diseases. 2022; 8(9): 1758-1814.
DEUEL JW. et al. Persistence, prevalence, and polymorphism of sequelae after COVID-19 in unvaccinated, young adults of the Swiss Armed Forces: a longitudinal, cohort study (LoCoMo). The Lancet Infectious Diseases. 2022; 22(12): 1694-1702.
DIAZ-AROCUPITA C, et al. Pericarditis in patientes whit COVID-19: a sistematic review. Journal of Cardiovascular Medicine. 2021; 22(9): 693-700.
GARCIA S, et al. Initial Findings from the North America COVID-19 Myocardical infarction Registry. Journal of American College of Cardiology. 2021; 77: 1994-2003.
HUANG N, et al. Systematic review and meta-analysis of the clinical outcomes of ACEI/ARB in Eats-Asian patients with COVID-19. 2023; 18(1): 0280280.
KHAWAJA S, et al. COVID-19 And Its impacto n the cardiovascular system. Open Heart. 2021; 8(1): 001472.
KINI A, et al. Types of myocardial injury and mid – term outcomes in patients whit COVID-19. European Heart Journal-Quality of care clinical outcomes. 2021; 7(5): 438-446.
KUNAL S, et al. Cardiovascular complications and its impact on outcomes in COVID-19. Indian Heart Journal. 2020; 72(6): 593-598.
LAÍREZ O, et al. Cardiac imagingphenotype in patients with coronavirus disease 2019 (COVID-19): results of the cocarde study. International Journalof Cardiovascular Imaging. 2021; 37(2): 449-457.
MAGALHÃES BK, et al. The impact of chronic cardiovascular disease on COVID-19 clinical course. Journal of clinical and translational research. 2022; 8(4): 308-322.
MALATY M, et al. Incidence and treatmen of arrhythmias secundary to coronavirua infection in humans: A systematic review. European Journal of Clinical Investigation. 2020; 51(2): 13428.
MANCIA G, et al. Renin-Angiotensin-Aldosterone System Blockers and the risk of COVID-19. New England Journal of Medicine. 2020; 385(25): 2431-2440.
MARFELLA R, et al. SARS-COV-2 colonizes coronary thrombus and impairs heart micro circulation bed in asymptomatic SARS-CoV-2 positive subjects with acute myocardial infarction. CriticalCare. 2021; 25(1): 217-229.
NAGY É, et al. The Impact of Comorbidities and Obesity on the Severity and Outcome of COVID-19 in Hospitalized Patients—A Retrospective Study in a Hungarian Hospital. International Journal of Environmental Research and Public Health. 2023; 20(2): 1372-1387.
OLIVEIRA GMM, et al. Estatística Cardiovascular – Brasil 2021. Arq. Bras. Cardiol. 2022; 118(1): 115-373.
PARK B, et al. Impact of Cardiovascular Risk Factors and Cardiovascular Diseases on Outcomes in Patients Hospitalized with COVID-19 in Daegu Metropolitan City. Journal of Korean Medical Science. 2021; 6(2): 15.
RUSSO V, et al. Clinical characteristics and prognosis of hospitalized COVID‐19 patients with incident sustained tachyarrhythmias: A multicenter observational study. European Journal of Clinical Investigation. 2020; 50(12): 13387.
SAEED S, et al. The cardiovascular complications in COVID-19: Focus on acute cardiac injury. Pakistan Journal of Medical Sciences. 2021; 37(3): 908-912.
SANZ A, et al. New-onset atrial fibrillation during COVID-19 infection predicts poor prognosis. Cardiology Journal2020. 2021; 28(1): 34-40.
SATO K, et al. Impact of renin–angiotensin–aldosterone system inhibition on mortality in critically ill COVID-19 patients with pre-existing hypertension: a prospective cohort study. BMC Cardiovascular Disorders. 2022; 22(1): 132-144.
SHARMA, A, et al. COVID-19: A Review on the Novel Coronavirus Disease Evolution, Transmission, Detection, Control and Prevention. Viruses. 2020; 13(2): 202.
SHEEHAN M, et al. Echocardiography in suspected corona vírus infection: indications, limitations and impact on clinical management. Open Heart. 2021; 8(2): 001702.
SOUZA, ASR. et al. Aspectos gerais da pandemia de COVID-19. Revista Brasileira de Saúde Materno Infantil. 2021; 21(1): 29-45.
VILLALBA G, et al. Impact of the presence of heart disease, cardiovascular medications and cardiac events on outcome in COVID-19. Cardiology Journal. 2021; 28(3): 960-368.
YE Z, et al. COVID-19 and the cardiovascular system: a comprehensive review. Journal of Huma Hypertension. 2020; 30(8): 4381-1389.